A citation-based method for searching scientific literature

Molecular subgroups of medulloblastoma: the current consensus.
Michael D Taylor, Paul A Northcott, Andrey Korshunov, Marc Remke, Yoon-Jae Cho, Steven C Clifford, Charles G Eberhart, D Williams Parsons, Stefan Rutkowski, Amar Gajjar, David W Ellison, Peter Lichter, Richard J Gilbertson, Scott L Pomeroy, Marcel Kool, Stefan M Pfister. Acta Neuropathol 2012
Times Cited: 1074



Risk stratification of childhood medulloblastoma in the molecular era: the current consensus.
Vijay Ramaswamy, Marc Remke, Eric Bouffet, Simon Bailey, Steven C Clifford, Francois Doz, Marcel Kool, Christelle Dufour, Gilles Vassal, Till Milde, Olaf Witt, Katja von Hoff, Torsten Pietsch, Paul A Northcott, Amar Gajjar, Giles W Robinson, Laetitia Padovani, Nicolas André, Maura Massimino, Barry Pizer, Roger Packer, Stefan Rutkowski, Stefan M Pfister, Michael D Taylor, Scott L Pomeroy. Acta Neuropathol 2016
Times Cited: 305




List of shared articles



Times cited

Clinical Audit of Survival Outcomes and Prognostic Factors in Adolescents and Adults with Medulloblastoma.
Roshankumar Patil, Tejpal Gupta, Madan Maitre, Archya Dasgupta, Ayushi Sahay, Sridhar Epari, Neelam Shirsat, Abhishek Chatterjee, Rahul Krishnatry, Jayant Sastri Goda,[...]. J Adolesc Young Adult Oncol 2022
2

Gene-Specific DNA Methylation Profiles in Pediatric Medulloblastomas.
Naz Kanit, Ozge Uysal Yoca, Dilek Ince, Nur Olgun, Erdener Ozer. Pediatr Dev Pathol 2022
0

DNA Methylation Profiling: An Emerging Paradigm for Cancer Diagnosis.
Antonios Papanicolau-Sengos, Kenneth Aldape. Annu Rev Pathol 2022
4

Magnetic Resonance Imaging in the Contemporary Management of Medulloblastoma: Current and Emerging Applications.
Archya Dasgupta, Madan Maitre, Sona Pungavkar, Tejpal Gupta. Methods Mol Biol 2022
1

Multidisciplinary Management of Medulloblastoma: Consensus, Challenges, and Controversies.
Abhishek Chatterjee, Madan Maitre, Archya Dasgupta, Epari Sridhar, Tejpal Gupta. Methods Mol Biol 2022
0

Identification and Functional Analysis of a Novel CTNNB1 Mutation in Pediatric Medulloblastoma.
Lide Alaña, Caroline E Nunes-Xavier, Laura Zaldumbide, Idoia Martin-Guerrero, Lorena Mosteiro, Piedad Alba-Pavón, Olatz Villate, Susana García-Obregón, Hermenegildo González-García, Raquel Herraiz,[...]. Cancers (Basel) 2022
0

Medulloblastoma: WHO 2021 and Beyond.
Jennifer A Cotter, Cynthia Hawkins. Pediatr Dev Pathol 2022
0

Elevated Kir2.1/nuclear N2ICD defines a highly malignant subtype of non-WNT/SHH medulloblastomas.
Yan-Xia Wang, Haibo Wu, Yong Ren, Shengqing Lv, Chengdong Ji, Dongfang Xiang, Mengsi Zhang, Huimin Lu, Wenjuan Fu, Qing Liu,[...]. Signal Transduct Target Ther 2022
0

Intratumoral heterogeneity of MYC drives medulloblastoma metastasis and angiogenesis.
Nan Qin, Eunice Paisana, Maike Langini, Daniel Picard, Bastian Malzkorn, Carlos Custódia, Rita Cascão, Frauke-Dorothee Meyer, Lena Blümel, Sarah Göbbels,[...]. Neuro Oncol 2022
0

Essential Management of Pediatric Brain Tumors.
Katharina Lutz, Stephanie T Jünger, Martina Messing-Jünger. Children (Basel) 2022
0

A Holistic Review on the Current and Future Status of Biology-Driven and Broad-Spectrum Therapeutic Options for Medulloblastoma.
Ariana Pritha, Richard Anderson, David E Anderson, Theodore Nicolaides. Cureus 2022
0

New Developments in the Pathogenesis, Therapeutic Targeting, and Treatment of Pediatric Medulloblastoma.
Francia Y Fang, Jared S Rosenblum, Winson S Ho, John D Heiss. Cancers (Basel) 2022
0

From sorting to sequencing in the molecular era: the evolution of the cancer stem cell model in medulloblastoma.
Tamra E Werbowetski-Ogilvie. FEBS J 2022
1

Clinically Tractable Outcome Prediction of Non-WNT/Non-SHH Medulloblastoma Based on TPD52 IHC in a Multicohort Study.
Alberto Delaidelli, Christopher Dunham, Mariarita Santi, Gian Luca Negri, Joanna Triscott, Olga Zheludkova, Andrey Golanov, Marina Ryzhova, Konstantin Okonechnikov, Daniel Schrimpf,[...]. Clin Cancer Res 2022
0

Clinical Trials in High-Risk Medulloblastoma: Evolution of the SIOP-Europe HR-MB Trial.
Simon Bailey, Nicolas André, Lorenza Gandola, Maura Massimino, Stefan Rutkowski, Steven C Clifford. Cancers (Basel) 2022
0

Prognostic impact of semantic MRI features on survival outcomes in molecularly subtyped medulloblastoma.
Archya Dasgupta, Tejpal Gupta, Madan Maitre, Babusha Kalra, Abhishek Chatterjee, Rahul Krishnatry, Jayant Sastri Goda, Neelam Shirsat, Sridhar Epari, Ayushi Sahay,[...]. Strahlenther Onkol 2022
0

Risk Stratification of Childhood Medulloblastoma Using Integrated Diagnosis: Discrepancies with Clinical Risk Stratification.
Hee Won Cho, Hyunwoo Lee, Hee Young Ju, Keon Hee Yoo, Hong Hoe Koo, Do Hoon Lim, Ki Woong Sung, Hyung Jin Shin, Yeon-Lim Suh, Ji Won Lee. J Korean Med Sci 2022
0

Embryonal and non-meningothelial mesenchymal tumors of the central nervous system - Advances in diagnosis and prognostication.
David M Meredith, Sanda Alexandrescu. Brain Pathol 2022
1

Enrichment of Tumor-Infiltrating B Cells in Group 4 Medulloblastoma in Children.
Kuo-Sheng Wu, Ting-Yan Jian, Shian-Ying Sung, Chia-Ling Hsieh, Man-Hsu Huang, Chia-Lang Fang, Tai-Tong Wong, Yu-Ling Lin. Int J Mol Sci 2022
0

Factors influencing outcomes of older children with medulloblastoma over 15 years in Peru, a resource-limited setting.
Rosdali Y Diaz-Coronado, James Brandon Reinecke, Joseph R Stanek, Jonathan L Finlay, Eddy Hernández Broncano, Sharon Chávez Paredes, Yesenia Miranda Tunque, Adela Heredia Zelaya, Sandro Casavilca Zambrano, Pamela García-Corrochano Medina,[...]. Pediatr Blood Cancer 2022
0

Circulating tumor DNA profiling for childhood brain tumors: Technical challenges and evidence for utility.
Anthony Pak-Yin Liu, Paul A Northcott, Giles W Robinson, Amar Gajjar. Lab Invest 2022
0

Medulloblastoma: A turning point from fundamental advances to improved survival and decreased sequelae.
P Chastagner. Neurochirurgie 2021
0

[Medulloblastoma. Pathology].
A Siegfried, M-B Delisle. Neurochirurgie 2021
0

Management of high-risk medulloblastoma.
E Bouffet. Neurochirurgie 2021
6

An extracellular vesicle-related gene expression signature identifies high-risk patients in medulloblastoma.
Thomas K Albert, Marta Interlandi, Martin Sill, Monika Graf, Natalia Moreno, Kerstin Menck, Astrid Rohlmann, Viktoria Melcher, Sonja Korbanka, Gerd Meyer Zu Hörste,[...]. Neuro Oncol 2021
4

Advances in the classification and treatment of pediatric brain tumors.
Jason Fangusaro, Pratiti Bandopadhayay. Curr Opin Pediatr 2021
5

Diagnostic Accuracy of a Reduced Immunohistochemical Panel in Medulloblastoma Molecular Subtyping, Correlated to DNA-methylation Analysis.
Arnault Tauziède-Espariat, Sophie Huybrechts, Emilie Indersie, Christelle Dufour, Stéphanie Puget, Anaïs Chivet, Alexandre Roux, Mélanie Pagès, Albane Gareton, Fabrice Chrétien,[...]. Am J Surg Pathol 2021
0

HDACs and MYC in medulloblastoma: how do HDAC inhibitors control MYC-amplified tumors?
Tomoko Shofuda, Yonehiro Kanemura. Neuro Oncol 2021
3

A Diagnostic Algorithm for Posterior Fossa Tumors in Children: A Validation Study.
C A P F Alves, U Löbel, J S Martin-Saavedra, S Toescu, M H Tsunemi, S R Teixeira, K Mankad, D Hargrave, T S Jacques, C da Costa Leite,[...]. AJNR Am J Neuroradiol 2021
2

The multilayer community structure of medulloblastoma.
Iker Núñez-Carpintero, Marianyela Petrizzelli, Andrei Zinovyev, Davide Cirillo, Alfonso Valencia. iScience 2021
0

Transcriptional control of DNA repair networks by CDK7 regulates sensitivity to radiation in MYC-driven medulloblastoma.
Bethany Veo, Etienne Danis, Angela Pierce, Dong Wang, Susan Fosmire, Kelly D Sullivan, Molishree Joshi, Santosh Khanal, Nathan Dahl, Sana Karam,[...]. Cell Rep 2021
5


Longstocking, LLC. © 2021
Home | About Us | FAQs | Terms & Privacy